查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497843

藥品和醫療設備組合產品市場：按產品、應用和最終用戶分類 - 全球預測 2024-2030

Drug-Device Combination Products Market by Product (Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps), Application (Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥品和醫療設備組合產品市場規模為1,339.5億美元，預計2024年將達到1,445.9億美元，2030年將達到2,310.5億美元，複合年成長率為8.09%。

藥品/醫療設備組合產品是將藥品與醫療設備融為一體的獨特保健產品。這些產品旨在透過整合藥物的藥理作用和醫療設備的物理性能來提供協同治療效果。藥物和醫療設備組合產品為未滿足的醫療需求或增強現有治療方法提供了創新的解決方案。藥物和醫療設備組合產品將藥物和器械結合在一個產品中，與單獨施用每種成分相比，可以實現更好的患者治療效果。這主要是由於藥物輸送到體內的特定部位，提高了療效，同時最大限度地減少了副作用和全身毒性。將智慧感測器等先進技術融入這些組合產品中，可以即時監控和控制藥物釋放曲線，從而促進根據個別患者需求量身定做的個人化醫療方法。此外，糖尿病和心臟病等慢性病的流行增加了對微創和標靶治療方法的需求。包括美國FDA在內的監管機構不斷簡化創新組合藥物的核准流程，為製造商創造了有利的環境。然而，複雜的法律規範和高成本的研發（R&D）活動成本極大地阻礙了藥物-醫療設備組合產品的採用。此外，製造商正在投資研發工作，以滿足靶向藥物傳輸系統和生物可吸收植入等領域未滿足的臨床需求。探索新的藥物和設備組合來對抗抗生素抗藥性感染疾病和增強癌症治療有望為藥物醫療設備組合產品的開發帶來希望。

主要市場統計
基準年[2023] 1339.5億美元
預測年份 [2024] 1445.9億美元
預測年份 [2030] 2310.5億美元
複合年成長率（%） 8.09%

區域洞察

在美洲，由於慢性病的增加、人口老化、技術進步和有利的報銷政策，對組合藥物和醫療設備產品的需求正在增加。美國食品藥物管理局(FDA) 積極參與支持藥物-醫療設備組合產品開發的專利核准和研究舉措。在亞太地區，中國、日本、印度和韓國等國家正專注於尋找具有成本效益的解決方案，以解決許多患有糖尿病和心血管疾病等慢性疾病的患者未得到滿足的醫療需求。中國國家監督監督管理局（NMPA）發布新的醫療設備臨床評估報告指南，以促進藥品醫療設備組合產品的進步。此外，日本的藥品和醫療設備法（PMD 法）保證藥品、醫療設備和類似產品的品質、有效性和安全性。歐盟國家對生物技術和醫療設備領域的投資迅速增加，與主題和關鍵字相關的研究活動不斷改進。歐洲藥品管理局 (EMA) 在評估這些產品的安全性和有效性方面發揮關鍵作用。領先的公司正在與學術機構合作開發滿足特定地區需求的創新解決方案。在中東和非洲地區，多個地區政府正在重點投資醫療基礎設施，為組合藥物和醫療設備產品的開發創造未來的成長機會。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在製藥/醫療設備組合產品市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對製藥和醫療設備綜合市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在藥品和醫療設備綜合市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病盛行率與標靶治療的重點
      • 政府對各種藥物/醫療設備組合產品的有利核准
      • 優先考慮微創手術以及使用抗菌和藥物釋放型支架
    • 抑制因素
      • 藥物/醫療設備組合產品的劑量和操作限制
    • 機會
      • 藥物/醫療設備組合產品的技術進步
      • 擴大藥品和醫療設備組合產品商業化的合併策略
    • 任務
      • 與客製化組合產品核准相關的監管障礙
  • 市場區隔分析
    • 產品：在外科手術中增加藥物釋放型支架和整形外科複合材料產品的使用
    • 應用：高效治療腫瘤和心血管疾病的藥物-醫療設備組合產品的新興需求
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 藥品/醫療設備組合產品市場：依產品

  • 抗菌導管
  • 藥物釋放型支架
  • 點滴幫浦
  • 吸入器
  • 整形外科複合產品
  • 動態治療儀
  • 預填充式注射器
  • 經皮吸收貼片
  • 創傷護理產品

第7章 藥品/醫療設備組合產品市場：依應用分類

  • 抗菌應用
  • 癌症治療
  • 心血管疾病
  • 糖尿病
  • 呼吸系統的問題

第8章 藥物/醫療設備組合產品市場：依最終用戶分類

  • 門診手術中心
  • 居家照護設置
  • 醫院/診所

第9章北美和南美藥品和醫療設備組合產品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區醫藥及醫療設備組合產品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲藥品/醫療設備組合產品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭場景分析
    • Nemera 和 Nelson Labs Europe 加強合作夥伴關係，為客戶提供全面服務
    • Kindeva 和 Meridian 合併創建領先的製藥和醫療設備組合產品 CDMO
    • Terumo 宣布推出與 Kyowa Kirin 共同開發的藥物和醫療設備組合產品
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-742BD517D8D5

[189 Pages Report] The Drug-Device Combination Products Market size was estimated at USD 133.95 billion in 2023 and expected to reach USD 144.59 billion in 2024, at a CAGR 8.09% to reach USD 231.05 billion by 2030.

A drug-device combination product is a unique class of healthcare products that combines pharmaceuticals and medical devices in a single unit. These products are designed to provide synergistic therapeutic benefits by integrating the pharmacological action of drugs with the physical performance of devices. The drug-device combination product offers innovative solutions for unmet medical needs or enhances existing therapies. Drug-device combination products deliver better patient outcomes compared to each component administered separately by combining drugs and devices into one product. This is primarily due to drug-targeted delivery at specific sites within the body, which increases efficacy while minimizing side effects or systemic toxicity. Incorporating advanced technologies, including smart sensors in these combination products, enables real-time monitoring and control over drug release profiles, which fosters personalized medicine approaches tailored to individual patient needs. Moreover, the prevalence of chronic diseases, including diabetes and heart ailments, has raised the need for minimally invasive and targeted treatment options. Ongoing efforts by regulatory authorities, including the U.S. FDA, to streamline approval processes for innovative combination products provide a favorable environment for manufacturers. However, complex regulatory frameworks and the high cost of research and development (R&D) activities significantly impede the adoption of drug-device combination products. In addition, manufacturers invest in research and development activities to address unmet clinical needs in areas such as targeted drug delivery systems or bioresorbable implants. Exploring new drug-device combinations to fight antibiotic-resistant infections or enhance cancer therapies is expected to create prospects for developing drug-device combination products.

KEY MARKET STATISTICS
Base Year [2023] USD 133.95 billion
Estimated Year [2024] USD 144.59 billion
Forecast Year [2030] USD 231.05 billion
CAGR (%) 8.09%

Regional Insights

In the Americas, there is a growing need for drug-device combination products due to the increasing prevalence of chronic diseases, the aging population, technological advancements, and favorable reimbursement policies. The U.S. Food and Drug Administration (FDA) has been actively involved in approving patents and supporting research initiatives to develop drug-device combination products. In the Asia-Pacific, countries including China, Japan, India, and South Korea focus on cost-effective solutions to address unmet medical needs for their large patient pool suffering from chronic illnesses such as diabetes or cardiovascular diseases. China's National Medical Products Administration (NMPA) released new guidelines on clinical evaluation reports for medical devices promoting advancements in drug-device combination products. In addition, Japan's Pharmaceuticals and Medical Devices (PMD) Act ensures the quality, efficacy, and safety of pharmaceuticals, medical devices, and similar products. European Union countries have witnessed a surge in investment within biotechnology and medical device sectors, improving research activities on drug-device combination products. The European Medicines Agency (EMA) plays a vital role in evaluating these products' safety and efficacy. Major players collaborate with academic institutions to develop innovative solutions catering to specific regional demands. In the Middle East and Africa region, several regional governments focus on investing in healthcare infrastructure development that provides future growth opportunities for developing drug-device combination products.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug-Device Combination Products Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Prevalence of chronic disease and emphasis on targeted treatments
      • Favorable government approvals for various drug-device combination products
      • Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
    • Market Restraints
      • Dosing and operational limitations of drug-device combination products
    • Market Opportunities
      • Technological advancements in drug-device combination products
      • Amalgamation strategies to expand drug-device combination product commercialization
    • Market Challenges
      • Regulatory hurdles associated with approval of customized combination products
  • Market Segmentation Analysis
    • Product: Increasing use of drug eluting stents and orthopedic combination products in surgical procedures
    • Application: Emerging need of drug-device combination products for efficient treatment across oncology and cardiovascular disorder
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug-Device Combination Products Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug-Device Combination Products Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Nemera and Nelson Labs Europe trengthen partnership to offer integrated services to customer

Nemera, a provider of drug delivery device solutions and combination product services, announced strengthening its existing partnership with Nelson Labs Europe, a significant player across the globe in microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. This non-exclusive collaboration allowed Nemera to access extractables & leachables, biocompatibility, microbiology, and chemical testing from Nelson Labs, delivering an integrated service offering to clients for their drug/device combination products and accelerating their market entry. They anticipated a productive collaboration, enhancing their mutual capabilities in providing superior solutions in the medical device and pharmaceutical sectors. [Published On: 2023-03-14]

Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO

Kindeva Drug Delivery and Meridian Medical Technologies completed their merger, resulting in the formation of a global Contract Development and Manufacturing Organization (CDMO) specializing in drug-device combination products. This merger aimed to expand the range of drug delivery capabilities by leveraging expertise and technology across parenteral, inhalation, transdermal, and intradermal administration routes. [Published On: 2022-12-12]

Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin

Terumo Corporation launched G-Lasta Subcutaneous Injection 3.6 mg BodyPod, a novel drug-device combination product created in collaboration with Kyowa Kirin Co., Ltd. The activated device is attached to the patient's body at the clinic during chemotherapy and automatically administers the drug approximately 27 hours later. The introduction of this advanced drug-device combination product streamlines treatment and reduces patient burden associated with post-chemotherapy visits. [Published On: 2022-12-06]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug-Device Combination Products Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug-Device Combination Products Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Braile Biomedica, Cardinal Health, Inc., CODAN Companies, Cook Group Incorporated, F. Hoffmann-La Roche AG, Fresenius Kabi, ICU Medical, Inc., InfuTronix, InSitu Technologies Inc., Insulet Corporation, JMS North America Corporation, Lepu Medical Technology Company, Medtronic PLC, MicroPort Scientific Corporation, Novartis AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., SOOIL Developments Co., Ltd., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Viatris Inc., W. L. Gore & Associates Inc., and Zyno Medical.

Market Segmentation & Coverage

This research report categorizes the Drug-Device Combination Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Antimicrobial Catheters
    • Drug Eluting Stents
    • Infusion Pumps
    • Inhalers
    • Orthopedic Combination Products
    • Photodynamic Therapy Devices
    • Prefilled Syringes
    • Transdermal Patches
    • Wound Care Products
  • Application
    • Antimicrobial Application
    • Cancer Treatment
    • Cardiovascular Disorder
    • Diabetes
    • Respiratory Problem
  • End-user
    • Ambulatory Surgery Centers
    • Home Care Settings
    • Hospital & Clinic
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disease and emphasis on targeted treatments
      • 5.1.1.2. Favorable government approvals for various drug-device combination products
      • 5.1.1.3. Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
    • 5.1.2. Restraints
      • 5.1.2.1. Dosing and operational limitations of drug-device combination products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in drug-device combination products
      • 5.1.3.2. Amalgamation strategies to expand drug-device combination product commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles associated with approval of customized combination products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing use of drug eluting stents and orthopedic combination products in surgical procedures
    • 5.2.2. Application: Emerging need of drug-device combination products for efficient treatment across oncology and cardiovascular disorder
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Drug-Device Combination Products Market, by Product

  • 6.1. Introduction
  • 6.2. Antimicrobial Catheters
  • 6.3. Drug Eluting Stents
  • 6.4. Infusion Pumps
  • 6.5. Inhalers
  • 6.6. Orthopedic Combination Products
  • 6.7. Photodynamic Therapy Devices
  • 6.8. Prefilled Syringes
  • 6.9. Transdermal Patches
  • 6.10. Wound Care Products

7. Drug-Device Combination Products Market, by Application

  • 7.1. Introduction
  • 7.2. Antimicrobial Application
  • 7.3. Cancer Treatment
  • 7.4. Cardiovascular Disorder
  • 7.5. Diabetes
  • 7.6. Respiratory Problem

8. Drug-Device Combination Products Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Home Care Settings
  • 8.4. Hospital & Clinic

9. Americas Drug-Device Combination Products Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug-Device Combination Products Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug-Device Combination Products Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Nemera and Nelson Labs Europe trengthen partnership to offer integrated services to customer
    • 12.3.2. Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO
    • 12.3.3. Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG-DEVICE COMBINATION PRODUCTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 175. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 302. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023